RESUMO
BACKGROUND: Dietary supplements are frequently used by healthy individuals and those with chronic medical conditions but may cause damage to the liver. The aim of this study was to examine the prevalence and attitudes of dietary supplement use, and the frequency of disclosure to healthcare providers among parents/caregivers for children with chronic liver disease. METHODS: We developed an anonymous survey for parents/caregivers of children (<18 years old) with chronic liver disease or liver transplant recipients and distributed the survey through social media groups organized around pediatric liver diseases. RESULTS: The survey was completed by 101 parents/caregivers (48 without transplant and 53 posttransplant).Among respondents, 87% agreed they would use dietary supplements to help their child, but parents/caregivers of transplant recipients were less likely to consider use (77% vs 98%; Pâ=â0.01). In the past 12 months, 83% reported dietary supplement use including 47% who used nonvitamin/mineral supplements. In two-thirds of parents/caregivers, use was initiated by their personal belief. Although 77% of respondents disclosed their use to their liver team, disclosure varied depending on the supplement with no individual that used cannabinoid products disclosing the use. CONCLUSIONS: Dietary supplements are frequently used by children with liver disease and may exceed use in other pediatric conditions. Though most parents report use to their liver team, disclosure may vary depending on the specific supplement. Providers should take extra measures to review use of supplements with their patients and work to develop trust with their families to obtain accurate disclosure of use.
Assuntos
Suplementos Nutricionais , Hepatopatias , Adolescente , Cuidadores , Criança , Humanos , PaisAssuntos
Atresia Biliar/cirurgia , Transplante de Fígado/métodos , Criança , Colangite/complicações , Colangite/cirurgia , Família , Humanos , Doadores Vivos , Masculino , Poder Familiar , PaisRESUMO
Serratia marcescens is a common nosocomial infection but a rare cause of osteomyelitis and more so of vertebral osteomyelitis. Vertebral osteomyelitis caused by this organism has been reported in few studies. We report a case of S. marcescens vertebral discitis and osteomyelitis affecting multiple non-contiguous vertebras. Although Staphylococcus aureus is the most common cause of vertebral osteomyelitis, rare causes, such as S. marcescens, need to be considered, especially when risk factors such as intravenous heroin use, post-spinal surgery and immunosuppression are present. Therefore, blood culture and where necessary biopsy of the infected region should be undertaken to establish the causative organism and determine appropriate antibiotic susceptibility. Prompt diagnosis of S. marcescens vertebral osteomyelitis followed by the appropriate treatment can achieve successful outcomes.
Assuntos
Osteomielite/microbiologia , Infecções por Serratia/complicações , Serratia marcescens/isolamento & purificação , Doenças da Coluna Vertebral/microbiologia , Antibacterianos/uso terapêutico , Ciprofloxacina/uso terapêutico , Humanos , Masculino , Meropeném , Pessoa de Meia-Idade , Osteomielite/tratamento farmacológico , Infecções por Serratia/tratamento farmacológico , Doenças da Coluna Vertebral/tratamento farmacológico , Tienamicinas/uso terapêutico , Resultado do TratamentoRESUMO
Telemedicine remains a valuable tool for obtaining health care services more than two years into the COVID-19 pandemic. As the US enters a new phase of pandemic recovery with virtual care firmly established as a care modality, telehealth regulations, models, and payments must transform for long-term sustainability. A thoughtful approach is essential to ensuring that the future of telemedicine removes disparities in health care access and outcomes instead of exacerbating them. Public health practice can shed light on how to address health inequities at the neighborhood level by using a data-driven approach, collaborating with communities, and designing policies with equity in mind.
Assuntos
COVID-19 , Telemedicina , Disparidades em Assistência à Saúde , Humanos , Pandemias/prevenção & controle , Saúde PúblicaRESUMO
OBJECTIVE: This study aimed to examine differences in completion rates between telepsychiatry and in-person visits during the COVID-19 pandemic and a prior reference period. METHODS: The authors used electronic medical record data along with chi-squared or t tests to compare patients' demographic characteristics. Generalized estimating equations for estimating the odds of primary and secondary outcomes were used, controlling for demographic characteristics. RESULTS: During COVID-19, the odds of completing a telepsychiatry visit (N=26,715) were 6.68 times the odds of completing an in-person visit (N=11,094). The odds of completing a telepsychiatry visit during COVID-19 were 3.00 times the odds of completing an in-person visit during the pre-COVID-19 reference period (N=40,318). CONCLUSIONS: In this cross-sectional study, outpatient adult mental health clinic telepsychiatry appointments, largely by telephone, were strongly associated with a higher rate of visit completion compared with in-person visits during and prior to the COVID-19 pandemic. Regulators should consider permanently enabling reimbursement for telephone-only telepsychiatry visits.
Assuntos
COVID-19 , Serviços de Saúde Mental/estatística & dados numéricos , Psiquiatria/métodos , Psiquiatria/estatística & dados numéricos , Telemedicina/organização & administração , Telemedicina/estatística & dados numéricos , Telefone , Adulto , COVID-19/epidemiologia , Estudos Transversais , Demografia , Registros Eletrônicos de Saúde , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais/estatística & dados numéricos , Pandemias , Fatores de Tempo , Estados Unidos/epidemiologiaRESUMO
New York City Health + Hospitals is the largest safety-net health care delivery system in the United States. Before the coronavirus disease 2019 (COVID-19) pandemic, NYC Health + Hospitals served more than one million patients annually, including the most vulnerable New Yorkers, while billing fewer than five hundred telehealth visits monthly. Once the pandemic struck, we established a strategy to allow us to continue to serve our existing patients while treating the surge of new patients. Starting in March 2020, we were able to transform the system using virtual care platforms through which we conducted almost eighty-three thousand billable televisits in one month, as well as more than thirty thousand behavioral health encounters via telephone and video. Telehealth also enabled us to support patient-family communication, postdischarge follow-up, and palliative care for patients with COVID-19. Expanded Medicaid coverage and insurance reimbursement for telehealth played a pivotal role in this transformation. As we move to a new blend of virtual and in-person care, it is vital that the major regulatory and insurance changes undergirding our COVID-19 telehealth response be sustained to protect access for our most vulnerable patients.